Clinical trial
Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
NCT06786936 is registered in ClinicalTrials.gov with NHS Greater Glasgow and Clyde as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 2, 2025
- Completion date
- April 30, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression, psoriatic arthritis, psoriatic plaque